SER   $7.94  3.01% Market Closed

Serina Therapeutics Inc
Total Cash 6.06M
totalCashPerShare 0.683
EBITDA -7.27M
Total Debt 11.71M
quickRatio 0.484
currentRatio 0.706
Total Revenue 3.17M
debtToEquity
Revenue/Share 0.787
ROA -0.45286
ROE
grossProfits
freeCashflow -5.93M
operatingCashflow -10.49M
earningsGrowth 3.57
revenueGrowth 6.286
grossMargins -0.3268
ebitdaMargins -2.29059
operatingMargins -75.803925
profitMargins -2.20871
enterpriseValue 72.76M
forwardPE
floatShares 2.92M
sharesOutstanding 8.88M
sharesShort 32.41K
sharesShortPriorMonth 28.77K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.58%
heldPercentInstitutions 0.02%
Short Ratio help_outline 2.72%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -1.861
Price To Book help_outline
earningsQuarterlyGrowth 5.44
netIncomeToCommon -7.01M
trailingEps 0.14%
forwardEps
enterpriseToEbitda -10.01
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 21
lastUpdated Oct. 17, 2024, 4:30 p.m.